Murray J. Casey, MD, MS, MBA
Murray J. Casey, MD, MS, MBA

Murray J. Casey, MD, MS, MBA

Professor
School of Medicine

Academic Appointments

Department

  • Obstetrics & Gynecology

Position

  • Professor

Education

  • MD, MS, MBA, PhD

Publications and Presentations

Books

  • Casey MJ, Bewtra C, Lynch HT, Snyder CL, Stacey M. Endometrial cancers in mutation carriers from Hereditary Breast Ovarian Cancer syndrome kindreds: report from the Creighton University Hereditary Cancer Registry with review of the implications, Int J Gynecol Cancer, International Journal Gynecol Cancer, 25:4, 2015
  • Casey MJ, Bewtra C, Lynch HT, Snyder CL, Stacey M. Endometrial cancers in mutation carriers from hereditary breast ovarian cancer syndrome kindreds. report from the Creighton University Hereditary Cancer Registry with review of the implications. Int J Gynecol Cancer., International Journal Gynecol Cancer, 25, 650-656, 2015
  • Zhuang W, Snyder C, Casey M, Stacey M, Lynch L. Female reproductive traits and lifespan in BRCA families. Am Soc Hum Genet 64th Annual Meeting, San Diego, CA, American Society of Human Genetics 64th Annual Meeting, 851, 2014
  • Casey MJ. The day the Word was made Flesh. Columbia, Not Applicable, 92(3), 23, 2014
  • Casey MJ, Salzman TA. Therapeutic, prophylactic, untoward and contraceptive effects of combined oral contraceptives. Catholic teaching, natural law and the principle of double effect when deciding to prescribe and use., Am J Bioethics, 14, 20-34, 2014
  • Genetics and Gynecologic Cancer in Hoskins WJ, Perez CA, Young RC (eds.) Principles and Practice of Gynecologic Oncology, 3rd Ed. (in press, 1999);, Not Applicable, 1999
  • Hereditary Cancer in Women in Greggi S (ed.) Familial and Hereditary Cancer in Women, 1999, (pp.24-46), Milan, Poletto Editore, Not Applicable, 1999

Articles

  • Snyder CL, Casey MJ, Lynch HT. Should prophylactic surgery to reduce cancer risks in mutation carriers from Hereditary Breast Ovarian Cancer syndrome families be confined to removal of the fallopian tubes with ovarian conservation? Women’s Health (in press, Not Applicable, 2015
  • Outcomes following implementation of symptom triggered diagnostic testing for ovarian cancer. Gynecol Oncol, 6/18/14., Gynecologic Oncology, 2014
  • CD44++/CD24+ -expressing cervical cells and cervical cancer radioresistant cells exhibit the same cancer stem cell characteristics. Gynecol Oncol, 3/19/14., Gynecologic Oncology, 2014
  • Peritoneal cytology: a risk factor of recurrence for non-endometrioid endometrial cancer, Gynecol Oncol,2/11/14., Gynecologic Oncology, 2014
  • Hardesty J, Xie QM, Casey MJ, Bewtra C. Factors affecting treatment response of endometrial hyperplasia., Modern Pathology, 22, 217A, 2009
  • Ethical challenges of pregnancy risk management programs, Cutis, 81, 494-500, 2008
  • Casey MJ, Snyder C, Bewtra C, Narod SA, Watson P, Lynch HT: Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of Hereditary Breast Ovarian Cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations., Gynecologic Oncology, 97, 457-467, 2005
  • Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P. Histology of ovaries prophylactically removed from BRCA1 and BRCA2 mutation carriers compared with noncarriers in Hereditary Breast Ovarian Cancer syndrome kindreds, Gynecol Oncol, 2000; 78:278-287., Gynecologic Oncology, 78, 278-287, 2001
  • Lynch HT, Casey MJ. Current status of prophylactic surgery for hereditary breast and gyneoclogic cancers, Current Opinion Obstet Gynecol, 2001; 13:25-30., Current Opinion Obstetrics & Gynecology, 13, 25-30, 2001
  • Lynch HT, Lynch JF, Casey MJ, Bewtra C, Narod SA. Genetics of gynecologic cancer. In: WJ Hoskins, CA Perez, RC Young (eds.) Principles and Practice of Gynecologic Oncology, 3rd ed., 2000, (pp. 29-53). Philadelphia, Lippincott Williams & Williams., Abstract Book, 29-53, 2000
  • Benign ovarian surface epithelium in BRCA1 positive women, Mod Pathol, 12:112A, 1999, Not Applicable, 1999
  • Casey MJ, Madden TJ. Endometrial screening of asymptomatic women by irrigation technique in the private gynecology office. J Amer Geriatric Soc, Not Applicable, 25:118-124, 1977
  • Snyder CL, Casey MJ, Lynch HT. Should prophylactic surgery to reduce cancer risks in mutation carriers from Hereditary Breast Ovarian Cancer syndrome families be confined to removal of the fallopian tubes with ovarian conservation? Women’s Health

Publications

  • Lynch HT, Casey MJ, Knezetic JA, Shaw TG, Lynch JF, Bewtra C: Hereditary factors in endometrial cancer, in Giordano A, Bovicelli A, Kurman RJ (eds.), Molecular Pathology of Gynecologic Cancer. 2005 (invited chapter pending publication).

Presentations

  • Casey MJ. "WHO 2014 Classification of Adnexal Cancers: Revisited and Applied" Department of Obstetrics and Gynecology Grand Rounds,Creighton University, Omaha, NE., 2016
  • Casey, MJ. Mullerian intra-abdominal carcinomatosis in Hereditary Breast Ovarian Cancer Syndrome: Implications for risk-reducing surgery. Dr. Henry T. Lynch Symposium: Advances in Hereditary Cancer, Omaha, Nebraska, 2015
  • Casey MJ. Should Prophylactic surgery to reduce cancer risk in mutation carrier from Hereditary Breast Ovarian Syndrome families be confirmed to removal of the fallopian tubes with ovarian conservation? Department of Obstetrics and Gynecology Grand Rounds, Creighton University Omaha, Nebraska, 2015
  • Casey, Mj. Gynecologic cancers in Lynch Syndrome. International Lynch Syndrome Conference, Lynch Syndrome International, Orlando, Florida, 2015
  • Rimsza RR, Tomsula JA, Colanta A, Casey MJ. Clinical-pathological characterization and classification of intrauterine polypoid lesions. (participated in preparation of Poster Presentation for the Annual Maurice Grier Symposium, Omaha, Nebraska, 2015
  • Krantz AM, Snyder CL, Stacey ML, Lynch HT, Casey MJ. Prevalence of endometriosis associated with gynecologic cancers in Hereditary Breast Ovarian Cancer syndrome and Lynch syndrome mutation carriers. (participated in preparation of Poster Presentation for the Annual Maurice Grier Symposium, Omaha, Nebraska, 2015
  • Casey MJ. Should prophylactic surgery to reduce cancer risks in mutation carriers from Hereditary Breast Ovarian Cancer syndrome families be confined to removal of the fallopian tubes with ovarian conservation? Formal discussant, New England Association of Gynecologic Oncologists 35th Annual Meeting, Kennebunkport, Maine, 2015
  • Casey MJ. Intra-abdominal carcinomatosis in mutation carriers from Hereditary Breast Ovarian Cancer syndrome families. Department of Obstetrics and Gynecology Grand Rounds,Creighton University, Omaha, NE, 2015
  • Casey MJ. Intra-abdominal carcinomatosis in mutation carriers from Hereditary Breast Ovarian Cancer syndrome families. Department of Obstetrics and Gynecology Grand Rounds,Creighton University, Omaha, NE., 2015
  • Casey MJ. Nonendometrioid uterine adenocarcinomas: Update. (Floor discussant: endometrial cancers in BRCA1 mutation carriers). Sunrise Seminar VI, Annual Meeting on Women’s Cancer, Society of Gynecologic Oncology, Chicago, IL., 2015
  • Casey MJ. Intra-abdominal carcinomatosis associated with hereditary gynecologic cancers. Presented to Kicks for a Cure, Executive Board Meeting hosted by Creighton University, 2015
  • Casey MJ. Intra-abdominal carcinomatosis associated with hereditary gynecologic cancers. Presented to Kicks for a Cure, Executive Board Meeting hosted by Creighton University, Omaha, Nebraska, 2015
  • Casey MJ. Gynecologic cancer in Lynch syndrome. Department of Obstetrics and Gynecology Grand Rounds, Creighton University, Omaha, NE., 2014
  • Casey MJ. Fiduciary Relationship, Love and Competence in Medical Care. Mid-Summer Lyceum, Creighton University Department of Obstetrics and Gynecology, Omaha, NE., 2014
  • Casey MJ. Gynecologic cancer in Lynch syndrome. Lynch Syndrome International Congress, Tampa, FL., 2014
  • A consortium to study endometrial cancer in women with HNPCC, Proceedings of the 3rd Joint Meeting Leeds Castle Polyposis Group and International Collaborative Group Hereditary Non-polyposis Colorectal Cancer, 2001., 2001
  • Gynecologic Oncology Rounds Second Monday of each month, 1999
  • Management of Hereditary Gynecologic Cancer Syndromes, Grand Rounds, Department of Obstetrics and Gynecology, April 14, 1999, 1999
  • Role of Genetic Testing in the Management of Women at Hereditary Risk for Female Cancers, Southeastern Wisconsin Cancer Conference, April 10, 1999, 1999
  • Benign ovarian surface epithelium in BRCA1 positive women, International Academy of Pathologists, March 20-26, 1999, 1999